Consolidated Financial Results, Form A, Auditors Report for March 31, 2016
Alembic Ltd has informed BSE about : 1. Consolidated Financial Results for the period ended March 31, 20162. Consolidated Form A for the period ended March 31, 20163. Consolidated Auditors Report for the period ended March 31, 2016 Board recommends Dividend
Alembic Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 26, 2016, inter alia, has recommended dividend of Rs. 0.15/- (7.5%) per Equity Share of face value of Rs. 2 each, subject to the approval of Shareholders at the ensuing Annual General Meeting.Further, the Board Meeting has been adjourned for considering the Consolidated Annual Audited Financial Results which will be prepared after giving effect... Standalone Financial Results, Form A, Auditors Report for March 31, 2016
Alembic Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Form A for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 2016 
Alembic forms joint venture with Orbicular for dermatology products
Alembic will hold 60% in the joint venture Aleor Dermaceuticals, Orbicular will hold the rest Board to consider Dividend
Alembic Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 26, 2016, inter alia, to transact the following business:1. To consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2016.2. To consider and recommend dividend on Equity Shares, if any, for the financial year ended March 31, 2016.... Shareholding for the Period Ended March 31, 2016
Alembic Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Alembic Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Outcome of Board Meeting (Appointment of Managing Director)
Alembic Ltd has informed BSE that Mr. Udit Amin has been serving the Company as Whole Time Director since April 24, 2013. Further the Company has informed that, the Board of Directors of the Company at its meeting held on March 28, 2016 has appointed Mr. Udit Amin as Managing Director of the Company w.e.f. March 28, 2016.The meeting commenced at 11:00 A.M. and concluded at 12:00 Noon. Shareholding for the Period Ended December 31, 2015
Alembic Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here